Name
Concurrent Breakfast | Tukysa (tucatinib) A Treatment Option for Patients with HER2+ Metastatic Breast Cancer (MBC)
Date & Time
Thursday, April 28, 2022, 7:00 AM - 7:45 AM
Speakers
Description
Speaker: Michel Velez, MD, Florida Cancer Specialists
Location Name
Atrium Ballroom A